Infusion Care

Option Care Health Leaders: ‘We Learned a Lot’ from Failed Amedisys Acquisition

Option Care Health (NYSE: OPCH), the home-based and alternate site infusion services provider, had one heck of a 2023. But, about six months removed from its failed attempt to acquire Amedisys Inc. (Nasdaq: AMED), it still remains a home-based care provider worth paying attention to. On Tuesday at the J.P. Morgan Healthcare Conference, the company’s […]

Option Care Health Leaders: ‘We Learned a Lot’ from Failed Amedisys Acquisition Read More »

Fresenius Medical Care Reports Divestitures, Including National Cardiovascular Partners

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has announced updates from transactions in 2023 as part of the Company’s ongoing Portfolio Optimization Program. Fresenius Medical Care has now signed and closed transactions exiting its Argentina operations with the sale to Grupo Olmos. The Company also closed

Fresenius Medical Care Reports Divestitures, Including National Cardiovascular Partners Read More »

Scroll to Top